Amgen

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing

Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries

CEO Name:
Robert Bradway
Executive Director

Contact
KS
Kathy Sherman
601 13th Street, NW, 12th Floor
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
John Benske Exclusive Duties N/A Authorized On 5/31/2017 Withdrawn On 9/1/2017
Scott Stenger Exclusive Duties N/A Authorized On 12/12/2017 Withdrawn On N/A
Kevin Johnson Exclusive Duties N/A Authorized On 6/12/2018 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 679
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

For
Notification Date
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

2017 Wisconsin Act 149

For
Notification Date
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Substitution of interchangeable biosimilars
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/19/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$0.00
2017
July - December
$7,117.61
2018
January - June
$12,000.00
2018
July - December
$440.67
Total $19,558.27
Total Hours Communicating 2017
January - June
0.00
2017
July - December
4.00
2018
January - June
9.00
2018
July - December
0.00
Total 13.00
Total Hours Other 2017
January - June
0.00
2017
July - December
35.00
2018
January - June
23.50
2018
July - December
3.50
Total 62.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30 %
2018
January - June
40 %
2018
July - December
Total 33 %
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30 %
2018
January - June
60 %
2018
July - December
Total 43 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
40 %
2018
January - June
2018
July - December
Total 21 %

Minor Efforts

No minor efforts found.

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
100 %
2017
July - December
2018
January - June
2018
July - December
100 %
Total 5 %

Filed Statements of Lobbying Activity and Expenditures